Professional Documents
Culture Documents
109/L, segmenters 54%, lymphocytes 40%, monocytes 4%, eosinophils 2%, platelets 150 x 109/L, MCV 108
fl, MCH 35 pg, MCHC 36%
Discussion points:
1. What is your assessment? Give primary diagnosis and differentials.
2. Discuss your primary diagnosis in terms of:
a. Clinical manifestations/complications of the disease
b. Laboratory work-up
c. Management
d. Prognosis
Discussion points:
1. What laboratory tests and ancillary procedures can be requested to adequately stage this
patient?
2. What treatment options can be offered for this patient?
3. What systemic treatment can be given for this patient with hormone positive and Her2 neu
positive breast cancer?
UNIVERSITY OF SANTO TOMAS (UST) FACULTY OF MEDICINE & SURGERY AND UST HOSPITAL
Medicine II GIRHO Big Group Discussions (BGD) in Hematology & Oncology
Discussion points:
1. What is your assessment? Give primary diagnosis and differentials.
2. Discuss your primary diagnosis in terms of:
a. Clinical manifestations/complications of the disease
b. Laboratory work-up
c. Management
d. Prognosis
Case 3: A1C, A2C, B1C & B2C
AT, a 20 year old male, came in due right knee pain and swelling which he noted 3 days prior while
he was cleaning the house, temporarily relieved by cold compress and Mefenamic Acid. No history of
trauma noted. Significant family history includes a hemophilic uncle. . P.E. Vital signs: BP: 120/80, PR:
106/min, regular, RR: 20/min, regular, Temp: 37.20C. He had pink palpebral conjunctivae, anicteric sclerae,
no lymphadenopathies, no hepatosplenomegaly. Labs: CBC: Hb 125 g/L, RBC 4.0 x 1012/L, Hct 0.38, WBC:
8.5 x 109/L, segmenters 64%, lymphocytes 30%, monocytes 3%, eosinophils 3%, platelets 165 x 109/L, MCV
95 fl, MCH 31 pg, MCHC 32%.
Discussion points:
1. What is your assessment? Give primary diagnosis and differentials.
2. Discuss your primary diagnosis in terms of:
a. Clinical manifestations/complications of the disease
b. Laboratory work-up
c. Management
d. Prognosis
Case 4: A1D, A2D, B1D, B2D
A 40/F came in due to a progressively enlarging mass on her left neck which stated 8 months PTC.
She initially consulted with a general physician with assessment of TB adenitis for which she was given
anti Koch treatment for 6 months. Due to progression in size of neck mass despite treatment, patient was
referred to an ENT for which a biopsy done revealed an Undifferentiated Carcinoma. A nasal endoscopy
was done with note of a mass on the nasopharyngeal area. Biopsy of the nasopharyngeal mass also
showed the same result. Upon probing, patient also complained of having frequent tinnitus and decreased
hearing from her left ear since 3 months PTC. Physical examination was unremarkable except for a 5x4cm
mass on the left cervical area. She is a non-smoker but lives with husband who chain smokes. She is a nonalcoholic beverage drinker.
Discussion points:
1. What are the differential diagnosis for patients presenting with lymphadenopathies?
2. What laboratory tests and ancillary procedures can be requested to adequately stage this
patient?
3. What treatment options can be offered for this patient?
UNIVERSITY OF SANTO TOMAS (UST) FACULTY OF MEDICINE & SURGERY AND UST HOSPITAL
Medicine II GIRHO Big Group Discussions (BGD) in Hematology & Oncology
g/L, Hct 0.20, WBC: 365 x 109/L, blasts 4%, promyelocytes 4%, myelocytes 12%, metamyelocytes 10%,
bands 8%, segmenters 32%, lymphocytes 19%, monocytes 4% eosinophils 3%, basophils 4%, platelets 680
x 109/L.
Discussion points:
1. What is your assessment? Give primary diagnosis and differentials.
2. Discuss your primary diagnosis in terms of:
a. Clinical manifestations/complications of the disease
b. Laboratory work-up
c. Management
d. Prognosis
Discussion points:
1. What are the different types of Germ Cell Tumor?
2. How do you differentiate Seminomatous from Nonseminomatous Germ Cell Tumor?
3. What laboratory tests can help differentiate between two types of germ cell tumors and help in
prognosticating this patient?
4. What treatment option can be offered for this patient?